PT
CELU icon

Palantir Technologies’s Celularity CELU Stock Holding History

Palantir Technologies’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,873
Closed -$73.6K – 7
2023
Q1 		$73.6K Hold
11,873
– – 0.47% 12
2022
Q4 		$153K Hold
11,873
– – 0.46% 18
2022
Q3 		$274K Sell
11,873
-73,023
-86% -$2.22M 0.49% 20
2022
Q2 		$2.89M Sell
84,896
-72,886
-46% -$5.92M 2.96% 14
2022
Q1 		$13.7M Sell
157,782
-28,542
-15% -$1.71M 5.6% 8
2021
Q4 		$9.54M Buy
+186,324
New +$11.9M 4.32% 10

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFO
Biltmore Family Office Charlotte, North Carolina $716M AUM 21.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Palantir Technologies's CELU Position: Q2 2023 in Review

Palantir Technologies sold out of Celularity (CELU) in Q2 2023, closing a stake of 11,873 shares — an estimated $73.6K sold.

Palantir Technologies first reported a position in CELU in Q4 2021 and held it in 6 quarters. The position peaked at $13.7M in Q1 2022. 56 funds tracked by Wall St. Rank hold CELU as of Q2 2023.

  • Palantir Technologies reported no remaining Celularity position as of Q2 2023 after selling out during the quarter.
  • Palantir Technologies sold 11,873 Celularity shares in Q2 2023, an estimated $73.6K.
  • Palantir Technologies first reported a position in Celularity in Q4 2021 and held it in 6 quarters.
  • Palantir Technologies's Celularity position peaked at $13.7M in Q1 2022.
  • 56 funds tracked by Wall St. Rank held Celularity as of Q2 2023.

Based on Palantir Technologies's 13F filing for Q2 2023, filed 14 Aug 2023.